Abstract
The application of stem cell biology to repair of the heart offers therapeutic potential. However, randomized, double-blind, controlled trials are required to clarify under what conditions it may be effective. The unprecedented nature of the discovery of a therapeutic role for autologous stem cells brings with it unprecedented challenges in clinical application of basic biology, ethics, funding and organization. It is suggested that the academic community should show leadership.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mathur A and Martin JF (2004) Stem cells and repair of the heart. Lancet 364: 183–192
Dimmeler S et al. (2005) Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 115: 572–583
Martin J (2005) Collaboration in cardiovascular stem-cell research. Lancet 365: 2070–2071
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Martin, J. Stem cells and the heart: ethics, organization and funding. Nat Rev Cardiol 3 (Suppl 1), S136–S137 (2006). https://doi.org/10.1038/ncpcardio0445
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio0445